Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am 1990 Apr;4(2):389-404

Date

04/01/1990

Pubmed ID

2182598

DOI

10.1016/s0889-8588(18)30494-5

Scopus ID

2-s2.0-0025253450 (requires institutional sign-in at Scopus site)   45 Citations

Abstract

Philadelphia chromosome (Ph)-negative chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia (CMML) are heterogeneous disorders characterized by various degrees of proliferation, dysplasia, maturation arrest, and monocytosis. In this article, the clinical, laboratory, molecular, and therapeutic aspects of the disease entities are reviewed.

Author List

Kantarjian HM, Kurzrock R, Talpaz M

Author

Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Aged
Antineoplastic Agents
Bone Marrow Transplantation
Cohort Studies
Combined Modality Therapy
Female
Humans
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Leukemia, Myelomonocytic, Chronic
Male
Middle Aged
Oncogenes
Prognosis
Risk Factors